Tenascin-C expression in ultrastructurally defined angiogenic and vasculogenic lesions

Ultrastructural Pathology

Volumn 21, Issue 6, 1997, Pages 537-544

  Kostianovsky, Mery ^a   Greco, M Alba ^b   Cangiarella, Joan ^c   Zagzag, David ^b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^c NEW YORK UNIVERSITY   (United States)

Author keywords

Angiogenesis; Tenascin; Vascular lesions; Vasculogenesis

Indexed keywords

TENASCIN;

ANGIOGENESIS; ARTICLE; EXTRACELLULAR MATRIX; HUMAN; HUMAN TISSUE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; VASCULAR LESION; VASCULAR TUMOR;

EID: 0030662204     PISSN: 01913123     EISSN: None     Source Type: Journal    
DOI: 10.3109/01913129709016370     Document Type: Article

References (46)

1. Jones FS, Burgoon MP, Hoffman S, et al. A cDNA clone for cytotactin contains sequences similar to epidermal growth factor-like repeats and segments of fibronectin and fibrinogen. Proc Natl Acad Sci USA. 1988;85:2186-2190.
2. Erickson HP. Tenascin-C, tenascin-R, and tenascin-X: a family of talented proteins in search of functions. Curr Opinion Cell Biol. 1993;5:869-876.
3. Grumet M, Hoffman S, Crossin KL, et al. Cytotactin, an extracellular matrix protein of neural and non-neural tissues that mediates glia-neuron interaction. Proc Natl Acad Sci USA. 1985;82:8075-8079.
4. Chiquet-Ehrismann R, Mackie EJ, Adams Pearson C, et al. Tenascin: an extracellular matrix protein involved in tissue interactions during fetal development and oncogenesis. Cell. 1986;47:131-139.
5. Chiquet M, Fambrough DM. Chick myotendinous antigen, I: a monoclonal antibody as marker for tendon and muscle morphogenesis. J Cell Biol. 1984;98:1926-1936.
6. Chiquet M, Fambrough DM. Chick myotendinous antigen, II: a novel extracellular glycoprotein complex consisting of large disulfide-linked subunits. J Cell Biol. 1984;98:1937-1946.
7. Mackie EJ, Thesleff I, Chiquet-Ehrismann R. Tenascin is associated with chondrogenic and osteogenic differentiation in vivo and promotes chondrogenesis in vitro. J Cell Biol. 1987;105:2569-2579.
8. Kruse J, Keilhauer G, Faissner A, et al. The J1 glycoprotein-a novel nervous system cell adhesion molecule of the L2/HNK-1 family. Nature (London). 1985;316:146-148.
9. Howeedy AA, Virtanen I, Laitinen L, et al. Differential distribution of tenascin in the normal, hyperplastic, and neoplastic breast. Lab Invest. 1990;63:71-79.
10. Tiitta O, Wahlstron T, Virtanen I, et al. Tenascin in inflammatory conditions and neoplasms of the urinary bladder. Virchows Arch [B]. 1993;63:283-287.
11. Soini Y, Paakko P, Nuorva K, et al. Tenascin immunoreactivity in lung tumors. Am J Clin Pathol. 1993;100:145-150.
12. Sasano H, Nagura H, Watanabe K, et al. Tenascin expression in normal and abnormal human endometrium. Mod Pathol. 1993;6:323-326.
13. Van Eyken P, Sciot R, Desmet VJ, et al. Expression of the novel extracellular matrix component tenascin in normal and diseased human liver. J Hepatol. 1990;11:43-52.
14. Ibrahim SN, Lightner VA, Ventimiglia JB, et al. Tenascin expression in prostatic hyperplasia, intraepithelial neoplasia, and carcinoma. Hum Pathol. 1993;24:982-989.
15. Shikata N, Oyaizu T, Andachi H, et al. Tenascin expression in normal human adult skin and skin appendage tumours. Virchows Arch. 1994;424:511-516.
16. Koukoulis GK, Gould VE, Bhattacharyya A, et al. Tenascin in normal, reactive, hyperplastic, and neoplastic tissues: biologic and pathologic implications. Hum Pathol. 1991;22:636-643.
17. Webersinke G, Bauer H, Amberger A, et al. Comparison of gene expression of extracellular matrix molecules in brain microvascular endothelial cells and astrocytes. Biochem Biophys Res Commun. 1992;189:877-884.
18. Ramadori G, Schwogler S, Veit TH, et al. Tenascin gene expression in rat liver and in rat liver cells: in vivo and in vitro studies. Virchows Arch [B]. 1991;60:145-153.
19. Canfield AE, Schor AM. Evidence that tenascin and thrombospondin-1 modulate sprouting of endothelial cells. J Cell Sci. 1995;108:797-809.
20. Zagzag D, Friedlander DR, Miller DC, et al. Tenascin expression in astrocytomas correlates with angiogenesis. Cancer Res. 1995;15:907-914.
21. Mackie EJ, Halfter W, Liverani D. Induction of tenascin in healing wounds. J Cell Biol. 1988;107:2757-2767.
22. Zagzag D, Friedlander DR, Dosik J, et al. Tenascin-C expression by angiogenic vessels in human astrocytomas and by human brain endothelial cells in vitro. Cancer Res. 1996;56:182-189.
23. Schinella RA, Greco MA. Bacillary angiomatosis presenting as a soft-tissue tumor without skin involvement. Hum Pathol. 1990;21:567-569.
24. Zagzag D, Yang G, Seidman I, et al. Malignant epithelioid hemangioendothelioma arising in an intramuscular lipoma. Cancer. 1993;71:764-768.
25. Kostianovsky M, Greco MA. Angiogenic process in bacillary angiomatosis. Ultrastruct Pathol. 1994;18:349-355.
26. Rosai J, Summer WH, Kostianovsky M, et al. Angiosarcoma of the skin: a clinicopathologic and fine structural study. Hum Pathol. 1976;7:83-109.
27. Erickson HP, Bourdon MA. Tenascin: an extracellular matrix protein prominent in specialized embryonic tissues and tumors. Annu Rev Cell Biol. 1989;5:71-92.
28. Mackie EJ, Chiquet-Ehrismann R, Adams Pearson C, et al. Tenascin is a stromal marker for epithelial malignancy in the mammary gland. Proc Natl Acad Sci USA. 1987;84:4621-4625.
29. Tiitta O, Sipponen P, Gould V, et al. Tenascin expression in inflammatory, dysplastic and neoplastic lesions of the human stomach. Virchows Arch. 1994;425:369-374.
30. Dvorak HF. Tumors: Wounds that do not heal. N Engl J Med. 1986;25:1650-1655.
31. Natali PG, Nicotra MR, Bartolazzi A, et al. Expression and production of tenascin in benign and malignant lesions of melanocytic lineage. Int J Cancer. 1990;46:586-590.
32. Weiss WS, Enzinger FM. Epitheliod hemangioendothelioma: a vascular tumor often mistaken for a carcinoma. Cancer. 1982;50:970-981.
33. Kostianovsky M, Lamy Y, Greco MA. Immunohistochemical and electron microscopic profiles of cutaneous Kaposi's sarcoma and bacillary angiomatosis. Ultrastruct Pathol. 1992;16:629-640.
34. Sriramarao P, Mendier M, Bourdon MA. Endothelial cell attachment and spreading on human tenascin is mediated by α 2β1 and α v β3 integrins. J Cell Sci. 1993;105:1001-1012.
35. Pietro AL, Anderson-Fisone C, Crossin KL. Characterization of multiple adhesive and counter adhesive domains in the extracellular matrix protein cytotactin. J Cell Biol. 1992;119:663-678.
36. Brooks PC, Clark RAF, Cheresh DA. Requirement of vascular integrin α v β3 for angiogenesis. Science (Washington, DC). 1994;264:596-597.
37. Wagner RC. Endothelial cell embryology and growth. Adv Microcirc. 1980;9:45-75.
38. Risau W, Sariola H, Zerwes G-H, et al. Vasculogenesis and angiogenesis in embryonic-stem-cell derived embryoid bodies. Development. 1988;102:471-478.
39. Folkman J, Haudenschild C. Angiogenesis in vitro. Nature. 1980;288:551-556.
40. Konerding MA, Van Ackern C, Steinberg F, et al. Combined morphological approaches in the study of network formation in tumor angiogenesis. In Steiner R, Weisz PB, Lanzer R, eds. Angiogenesis. Basel, Switzland: Birkhauser; 1992:40-58.
41. Sharifi BG, LaFleur DW, Pirola CJ, et al. Angiotensin II regulates tenascin gene expression in vascular smooth muscle cells. J Biol Chem. 1992;267:23910-23915.
42. Adams Pearson CA, Pearson D, Shibahara S, et al. Tenascin: cDNA cloning and induction of TGF-β. EMBO J. 1988;7:2677-2981.
43. Meiners S, Marone M, Rittenhouse JL, et al. Regulation of astrocytic tenascin by basic fibroblast growth factor. Dev Biol. 1993;160:480-493.
44. Brodkey JA, Laywell ED, O'Brien TF, et al. Focal brain injury and upregulation of a developmentally regulated extracellular matrix protein. J Neurosurg. 1995;82:106-112.
45. Ensoli B, Gendelman R, Markham P, et al. Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcoma. Nature (London). 1994;371:674-680.
46. End P, Panayotou G, Entwistle A, et al. Tenascin: a modulator of cell growth: Eur J Biochem. 1992;209:1041-1051.